MedTrace Logo

Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patients With Borderline Personality Disorder

NCT06699732 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-09-02

No results posted yet for this study

Summary

The primary purpose of the study is to investigate whether Mindful Self-Compassion (MSC) therapy can significantly reduce self-harm behaviors, improve emotional regulation, and enhance the quality of life in individuals diagnosed with Borderline Personality Disorder (BPD). The study aims to contribute to the existing literature by providing robust evidence on the efficacy of MSC therapy for BPD, which could inform clinical practices and improve treatment outcomes

Conditions

  • Psychological Distress
  • Emotional Regulation
  • Self Harm
  • Quality of Life (QOL)
  • Borderline Personality Disorder (BPD)

Interventions

BEHAVIORAL

Mindful Self Compassion Therapy

Mindful Self-Compassion (MSC) therapy is an 8-week program blending mindfulness and self-compassion to improve emotional resilience and well-being. Week 1: Introduction - Learn the basics of mindfulness, self-compassion, and reframing self-critical thoughts with kindness. Week 2: Mindfulness - Practice observing thoughts and emotions without judgment to build self-awareness. Week 3: Self-Kindness - Develop skills to treat yourself with warmth and care during difficult times. Week 4: Common Humanity - Explore shared human experiences to reduce feelings of isolation. Week 5: Working with Challenges - Learn strategies to respond compassionately to emotional pain. Week 6: Growing Compassion - Deepen compassion for yourself and others through guided exercises. Week 7: Resilience Building - Strengthen coping skills and foster emotional flexibility. Week 8: Integration - Consolidate skills to maintain self-compassion in daily life.

Sponsors & Collaborators

  • Fatima Jinnah Women University

    lead OTHER

Principal Investigators

  • Asma Mansoor, PhD Scholar · Fatima Jinnah Women University, Rawalpindi, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-21
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06699732 on ClinicalTrials.gov